{"id":118324,"date":"2021-07-16T11:34:18","date_gmt":"2021-07-16T11:34:18","guid":{"rendered":"https:\/\/fin2me.com\/?p=118324"},"modified":"2021-07-16T11:34:18","modified_gmt":"2021-07-16T11:34:18","slug":"thai-hospital-tycoon-sticks-to-guns-on-vaccine-claims","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/thai-hospital-tycoon-sticks-to-guns-on-vaccine-claims\/","title":{"rendered":"Thai hospital tycoon sticks to guns on vaccine claims"},"content":{"rendered":"
BANGKOK (Reuters) – Thailand\u2019s Thonburi Healthcare Group Pcl (THG) doubled down on its outspoken chairman\u2019s claim to be buying Pfizer-BioNTech vaccines on Friday, helping its share price rise despite denials by both drugmakers.<\/p> Dr. Boon Vanasin\u2019s claim that his group, a more than $800 million private medicine empire, was close to signing a deal for 20 million Pfizer-BioNTech coronavirus vaccines to import to Thailand was swiftly denied on Thursday by both companies, one day after a government agency filed a defamation suit against Boon, 82.<\/p>\n On Friday, THG stuck to its guns.<\/p>\n \u201cTHG has agreed to buy the vaccine and is currently in the process of filing documents with overseas dealers,\u201d the company said in a statement.<\/p>\n Boon even told local media an agreement would be signed by Friday afternoon. By close of business, there was still no evidence of any deal.<\/p>\n THG shares closed 1.59% higher, having been up as much as 4% at one point.<\/p>\n It\u2019s still unclear whether Boon was insincere, the victim of a scam or – as he asserts – in the process of a brilliant fix to Thailand\u2019s desperate vaccine needs.<\/p>\n Boon insists a deal was in the works through a government agency, which he declined to name.<\/p>\n \u201cWe are not doing it directly,\u201d he told Reuters.<\/p>\n Still, his comments on Thursday added about 1.5 billion baht ($45.80 million) to THG\u2019s market capitalisation, bring it to 26.8 billion baht ($818.32 million), Refinitiv Eikon data shows.<\/p>\n Thailand so far has only vaccinated 5 percent of its population of more than 66 million. It has been administering China\u2019s Sinovac vaccine and the AstraZeneca\u2019s shots but the government seeking other imported doses.<\/p>\n Boon, the Thai word for merit, has been on a quest for COVID-19 vaccines for months, arguing that the government should not monopolise supply and calling the vaccine policy \u201ccomplacent and reckless.\u201d<\/p>\n In February, he tried to import vaccines, but was unsuccessful and later lodged a protest..<\/p>\n Months later state drugmaker, the Government Pharmaceutical Organization (GPO), said it would import five million doses of Moderna vaccine for private hospitals.<\/p>\n Demand for mRNA vaccines in Thailand is growing. Pre-orders for Moderna vaccines through private hospitals were snapped up in a hurry.<\/p>\n Boon criticised the GPO for its process and on Wednesday the GPO slapped a defamation suit against the John Hopkins-trained physician. He said he welcomed the complaint because evidence and documents could be revealed in court.<\/p>\n Boon founded Thonburi hospital in 1976 and oversaw its expansion into a network of seven hospitals with 963 registered beds. He took the company public in 2017.<\/p>\n THG, which also operates hospitals in Cambodia and Myanmar, booked losses of 215 million baht in the first quarter this year, taking a hit from the pandemic and drop off in medical tourists.<\/p>\n The group is smaller than rivals like Bangkok Dusit Medical Services Pcl, and before the pandemic, its chairman began to carve out a niche. In 2017, he launched a $500 million \u2018medical city\u2019 for the elderly called Jin Wellbeing County, targeting Thailand\u2019s ageing population and foreign retirees.<\/p>\n ($1 = 32.7500 baht)<\/p>\n